One of Europe’s largest active ETFs, the JPMorgan Europe Research Enhanced Equity Active ETF, manages to achieve enhanced returns despite tight constraints.
We initiate coverage with an ‘above average’ rating for both people and process.
Key Morningstar Metrics for JPMorgan Europe Research Enhanced Index Equity Active UCITS ETF JREE
- Morningstar Category: Europe Large-Cap Blend Equity
- Morningstar Medalist Rating: Silver
- Morningstar Rating: ★★★★
- Ongoing Charge: 0.24%
Piera Elisa Grassi has led the strategy since its launch in October 2018. Grassi joined JPMorgan in 2004, began managing money in 2007, and has been leading the global research enhanced index team since 2014. The team consists of seven portfolio managers who boast extensive industry experience and firm tenure.
JPMorgan’s fundamental research teams are crucial to the strategy’s success. Grassi leverages their insights to construct the portfolio with a highly systematic approach, drawing on her strong background in quantitative analysis and risk management. The research team are invested in the strategies they run, aligning their interests with those of investors.
The well-engineered and effectively-executed approach combines elements of index and quantitative active investing to enhance returns relative to a passive approach while keeping risks in check. Analyst insights are integrated into the portfolio with limited deviations from the strategy’s MSCI Europe Index benchmark, by applying small overweight or underweight positions at the stock level, while aiming for neutrality at the region, sector, or style levels.
Stock-picking is the main driver of relative returns. The strategy targets a tight tracking error of 0.75%-1.5% versus the MSCI Europe Index. The portfolio is broadly diversified across roughly 150 holdings, and the resulting active share tends to be around 35%.
From its inception in October 2018 through May 2025, the strategy has outperformed its benchmark, despite being managed within tight constraints.
The strategy’s annualized return surpassed the MSCI Europe Index by 0.92 percentage points and the Morningstar Developed Markets Europe Target Market Exposure Morningstar Category index by 0.76 percentage points.
It also significantly outperformed its typical Europe large-blend equity peers. This was achieved with similar volatility, leading to superior risk-adjusted returns as measured by the Sharpe ratio.
Additionally, the strategy also benefits from much lower fees than most of its active peers.
